Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|February 13, 2010
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuromaPreetha Rajaraman, Amy Hutchinson, Sara Wichner, et al.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Carcinogenesis|March 25, 2008
Notch-1 regulates transcription of the epidermal growth factor receptor through p53Benjamin W Purow, Tilak K Sundaresan, Michael J Burdick, et al.
Neuro-Oncology|April 7, 2006
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumorsAnneclaire J De Roos, Nathaniel Rothman, Merideth Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaTeri N Kreisl, Lyndon Kim, Kraig Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumorsAnneclaire J De Roos, Nat Rothman, Peter D Inskip, et al.
International Journal of Epidemiology|April 26, 2003
Sociodemographic indicators and risk of brain tumoursPeter D Inskip, Robert E Tarone, Elizabeth E Hatch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Risk of meningioma and common variation in genes related to innate immunityPreetha Rajaraman, Alina V Brenner, Gila Neta, et al.
Neuroepidemiology|March 12, 2003
Laterality of brain tumorsPeter D Inskip, Robert E Tarone, Elizabeth E Hatch, et al.
Plos One|April 15, 2014
Micro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cellsMehmet Baysan, Kevin Woolard, Serdar Bozdag, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|February 13, 2010
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuromaPreetha Rajaraman, Amy Hutchinson, Sara Wichner, et al.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Carcinogenesis|March 25, 2008
Notch-1 regulates transcription of the epidermal growth factor receptor through p53Benjamin W Purow, Tilak K Sundaresan, Michael J Burdick, et al.
Neuro-Oncology|April 7, 2006
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumorsAnneclaire J De Roos, Nathaniel Rothman, Merideth Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaTeri N Kreisl, Lyndon Kim, Kraig Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumorsAnneclaire J De Roos, Nat Rothman, Peter D Inskip, et al.
International Journal of Epidemiology|April 26, 2003
Sociodemographic indicators and risk of brain tumoursPeter D Inskip, Robert E Tarone, Elizabeth E Hatch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Risk of meningioma and common variation in genes related to innate immunityPreetha Rajaraman, Alina V Brenner, Gila Neta, et al.
Neuroepidemiology|March 12, 2003
Laterality of brain tumorsPeter D Inskip, Robert E Tarone, Elizabeth E Hatch, et al.
Plos One|April 15, 2014
Micro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cellsMehmet Baysan, Kevin Woolard, Serdar Bozdag, et al.
Pageof 17